Searchable abstracts of presentations at key conferences in endocrinology

ea0025s6.3 | Novel application of thyroid hormone analogues: thyroid hormones, thinking outside the capsule | SFEBES2011

The action of thyroid hormone in vascular tissues

Davis Paul , Davis Faith , Lin Hung-Yun , Mousa Shaker

Iodothyronines stimulate neovascularization in tumor beds, brain, ischemic myocardium and striated muscle. The molecular basis of the action can be studied in models such as the chick chorioallantoic membrane (CAM) and human microvascular endothelial cell (HDMEC) microtubule formation. Nongenomic and genomic actions of the hormone may contribute to angiogenesis. The initial description of the cell surface receptor for thyroid hormone (T4 and 3,5,3′-triiodo-<sm...

ea0056p140 | Endocrine tumours and neoplasia | ECE2018

Achievement of therapeutic mitotane concentrations in management of advanced adrenocortical cancer: a single centre experience in 47 patients

Bakhit Mohamed , Whitelaw Benjamin C , Gilbert Jackie , Coskeran Patsy , Diaz-Cano Salvador , Taylor David R , Taylor Norman T , Ghatore Lea , Lewis Dylan , Vivian Gillian , Sarker Debashis , Ross Paul , Davis Laura May , Clough Jennifer , Hubbard Johnathan G , Galata Gabriele , Prachalias Andreas , Schulte Klaus-Martin , Aylwin Simon J B

Introduction: Multi-modal therapy for adrenocortical carcinoma (ACC) includes surgery, therapy with the adrenolytic agent mitotane and systemic chemotherapy. Achievement of therapeutic mitotane concentrations (≥14 mg/l) has been related to improved outcomes.Aim: To evaluate the effectiveness of a defined* high dose protocol mitotane therapy in patients with advanced ACC (stages III and IV).Methods: Review of patients presenti...